Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid is a synthetic small molecule belonging to the class of substituted phenylethane boronic acids. It is an experimental compound, not approved for clinical use, and has primarily been studied as a transition-state analog inhibitor of serine proteases such as chymotrypsin and subtilisin. The compound acts by mimicking the tetrahedral intermediate formed during peptide bond hydrolysis, covalently binding to the catalytic serine residue in the active site of these enzymes. This mechanism makes it useful for probing enzyme stereoselectivity and structure–activity relationships in protease inhibition research[9][2][1]. There are no known therapeutic indications or ongoing clinical trials for this molecule.
- Other names
- L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid((1R)-2-(4-chlorophenyl)-1-((1-hydroxyethylidene)amino)ethyl)trihydroxyboranuide[(1R)-2-(4-chlorophenyl)-1-[(1-hydroxyethylidene)amino]ethyl]trihydroxyboranuide
02
Targets
CTRC (Chymotrypsin C)
Beyond the preview
Go deeper on L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid.